Becton Dickinson

The firms will develop, manufacture, and commercialize flow cytometry-based companion diagnostics for cancer and other diseases.

The partners will offer their combined expertise to biopharma companies developing diagnostics and clinical decision-making tools.

The firms will collaborate to develop, manufacture, market, and commercialize companion diagnostic tests in oncology and other areas.